-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AZhYcrOHpMkKkFQ+RtaQFG/bfQ+5r4kD5XxEfnO3WDU+QxUjsHm3f6xxvnNmv4mN /Qi0btPdF6sdOjS+xfscPA== 0000891836-02-000559.txt : 20021114 0000891836-02-000559.hdr.sgml : 20021114 20021114164858 ACCESSION NUMBER: 0000891836-02-000559 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20021114 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20021114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACIA CORP /DE/ CENTRAL INDEX KEY: 0000067686 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 430420020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02516 FILM NUMBER: 02825696 BUSINESS ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 BUSINESS PHONE: 9089018000 MAIL ADDRESS: STREET 1: 100 ROUTE 206 NORTH CITY: PEAPACK STATE: NJ ZIP: 07977 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CHEMICAL CO DATE OF NAME CHANGE: 19711003 FORMER COMPANY: FORMER CONFORMED NAME: MONSANTO CO DATE OF NAME CHANGE: 19920703 8-K 1 sc0322.txt FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 --------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2002 PHARMACIA CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 1-2516 43-0420020 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 100 Route 206 North, Peapack, New Jersey 07977 (Address of Principal Executive Office) (Zip Code) 908-901-8000 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) N/A - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) ITEM 9. REGULATION FD DISCLOSURE. On November 14, 2002, in connection with the filing of Pharmacia Corporation's (NYSE: PHA) ("Pharmacia") quarterly report on Form 10-Q for the quarter ended September 30, 2002, Fred Hassan, Principal Executive Officer, and Christopher J. Coughlin, Principal Financial Officer, of Pharmacia submitted sworn statements to the Securities and Exchange Commission pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. A copy of each statement is attached to this Form 8-K and furnished herewith, pursuant to Item 9, as Exhibit 99.1 and Exhibit 99.2. -2- ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (C) EXHIBITS Exhibit No. Description - ----------- ----------- 99.1 Certification of Principal Executive Officer, dated November 8, 2002, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). 99.2 Certification of Principal Financial Officer, dated November 7, 2002, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). -3- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PHARMACIA CORPORATION Date: November 14, 2002 By: /s/ Don W. Schmitz ----------------------- Don W. Schmitz Vice President and Secretary -4- EXHIBIT INDEX Exhibit No. Description - ----------- ----------- 99.1 Certification of Principal Executive Officer, dated November 8, 2002, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). 99.2 Certification of Principal Financial Officer, dated November 7, 2002, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). -5- EX-99.1 3 ex-99_1.txt CERTIFICATION OF PRINCIPAL EXECUTIVE EXHIBIT 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Pharmacia Corporation (the "Company") on Form 10-Q for the period ending September 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Fred Hassan, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. /s/ Fred Hassan - ------------------------------------- Fred Hassan Chairman and Chief Executive Officer November 8, 2002 Subscribed and sworn to before me this 8th day of November 2002. /s/ Cecilia Rueda-Stephens - -------------------------- Notary Public My Commission Expires: Cecilia Rueda-Stephens A Notary Public of New Jersey My Commission Expires February 23, 2004 EX-99.2 4 ex-99_2.txt CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER EXHIBIT 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Pharmacia Corporation (the "Company") on Form 10-Q for the period ending September 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Christopher J. Coughlin, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C 1350, as adopted pursuant to ss. 906 of thE Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. /s/ Christopher J. Coughlin - --------------------------- Christopher J. Coughlin Executive Vice President and Chief Financial Officer November 7, 2002 Subscribed and sworn to before me this 7th day of November 2002. /s/ Deborah Rein - ---------------- Notary Public My Commission Expires: Deborah Rein A Notary Public of New Jersey My Commission Expires January 13, 2004 -----END PRIVACY-ENHANCED MESSAGE-----